tirzepatide used for diabetes Dosing: vs Weight Loss Mounjaro - Tirzepatide with injection

Clean math, no waste, and well within the 28-day stability window

Acting on both incretin hormones, GIP and GLP-1, tirzepatide helps the body regulate blood sugar more effectively while promoting more weight loss and offering additional metabolic benefits over previous medications

Reconstituted with 2 mL of bacteriostatic water (5 mg/mL), it provides exactly 4 doses of 2.5 mg, aligning perfectly with the 4-week initial dose period and the 28-day stability window

The US Food and Drug Administration approved this first-in-class medication for the management of type 2 diabetes (T2D) in 2022 [2], for the reduction of excess weight in adults with obesity or overweight in 2023 [3], and for moderate-to-severe obstructive sleep apnea (OSA) in people with obesity in 2024 [4]

Severe or persistent abdominal pain, especially if radiating to the back and accompanied by nausea or vomiting, may indicate acute pancreatitisa serious adverse effect requiring emergency evaluation

Insert the needle at a 45 to 90 degree angle, depending on how much subcutaneous fat is present